• Home
  • About us
  • Medical AI
    • AI Bone Age Diagnosis
    • Growth Assessment System
  • Sys Integration Services
  • Healthcare IoT Solution
  • Preventive Medicine
    • CTC Detection System
  • Health lecture tour
  • Cell Factory Solution
  • Contact Us
  • 更多
    • Home
    • About us
    • Medical AI
      • AI Bone Age Diagnosis
      • Growth Assessment System
    • Sys Integration Services
    • Healthcare IoT Solution
    • Preventive Medicine
      • CTC Detection System
    • Health lecture tour
    • Cell Factory Solution
    • Contact Us
  • Home
  • About us
  • Medical AI
    • AI Bone Age Diagnosis
    • Growth Assessment System
  • Sys Integration Services
  • Healthcare IoT Solution
  • Preventive Medicine
    • CTC Detection System
  • Health lecture tour
  • Cell Factory Solution
  • Contact Us

CTC helps you detect cancer cells earlier

Cancer stage

Circulating Tumor Cell (CTC)

Tumor size

Circulating Tumor Cell (CTC)

Applicable testing tools

Applicable testing tools

Circulating Tumor Cell (CTC)

Detection principle

The red blood cells are removed by using the difference in osmotic pressure, and then the white blood cells are identified by specific antibodies and removed using the exclusively licensed PowerMagTM magnetic column. For the products after the above negative screening, the system will automatically perform immunofluorescence staining and fully automatic microscopy photography, and finally the circulating tumor cells will be interpreted by the AI ​​imaging system.

Detection principle

CTC Circulating Tumor Cell Automated Detection

Circulating Tumor Cell (CTC)

Highlight

1. Negative selection

2. Convenient testing with only 2ml blood sample

3. Next-day results available 

4. Recognized by the National Innovation Award

5. Intact and live CTCs can be obtained

6. 4 samples in parallel (8 samples/day)

  • Independent liquid handling system and consumables,no cross-over contamination.

7. Modules integration: 

  • Included cell isolation, immunostaining, automated image acquisition, AI-assisted cell identification, report printing.

8. Customization: 

  • can be docked according to hospital information system (HIS) and customized report format.

9. Fully automated process: 

  • No manual intervention required for specimen preprocessing and high reproducibility.
  • Touch screen operation

Analysis software output images

CTC images of clinical specimens

Circulating Tumor Cell (CTC)

WBC images of clinical specimens

Circulating Tumor Cell (CTC)

Detect cancer

CATCHTM can detect more than 86.27% of cancer patients.

  • Rectal and Colon Cancer
  • Anal cancer
  • Liver cancer
  • Breast cancer
  • Gallbladder cancer
  • Prostate cancer
  • skin cancer
  • Pancreatic cancer
  • Kidney cancer
  • ovarian cancer
  • cervical cancer

  • Tracheal, bronchial or lung cancer
  • Bile duct cancer
  • Oral cancer
  • Thyroid cancer
  • Stomach cancer
  • Esophageal cancer
  • Bladder Cancer
  • Nasopharyngeal carcinoma
  • Laryngeal cancer
  • Urothelial carcinoma

CTC Detection Application

Advanced health examination service

Cross-industry collaboration with insurance companies

Cross-industry collaboration with insurance companies

Incorporating CTCs counts into the current tumor markers could provide a cancer risk index before the tumor is detected by imaging.

Cross-industry collaboration with insurance companies

Cross-industry collaboration with insurance companies

Cross-industry collaboration with insurance companies

Spillover insurance policyholders have a more comprehensive coverage through CTC detection before or after an insurance claim.

Early detection of cancer

Cross-industry collaboration with insurance companies

Early detection of cancer

CTC detection could be used for early cancer diagnosis to assess cancer risk.

Follow-up

Cancer medication guidelines

Early detection of cancer

Tumor response could be evaluated by monitoring the CTC status before and after a drug treatment

Cancer medication guidelines

Cancer medication guidelines

Cancer medication guidelines

Genome sequencing of CTCs could provide insights into selecting the optimal drugs for chemotherapy and targeted therapy

Cancer recurrence monitoring

Cancer medication guidelines

Cancer medication guidelines

Cancer patients could follow up on CTC counts regularly to evaluate whether or notthe cancer has recurred

Clinical sensitivity and specificity

Itcan Biotech Co., Ltd. passed the ISO 9001 quality management system certification

  • About us
  • Medical AI
  • Sys Integration Services
  • Preventive Medicine
  • Cell Factory Solution
  • Contact Us

Copyright © 2025 Itcan Biotech All Rights Reserved

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, you agree that your information will be combined with that of other users. 

ACCEPT